TumoralTP53and/orCDKN2Aalterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

TumoralTP53and/orCDKN2Aalterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group

Published:2014-12-02 Issue:5 Volume:62 Page:759-765
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Lerman Daniel M.¹²,Monument Michael J.¹²,McIlvaine Elizabeth³,Liu Xiao-qiong⁴,Huang Dali⁴,Monovich Laura⁵,Beeler Natalie⁵,Gorlick Richard G.⁶,Marina Neyssa M.⁷,Womer Richard B.⁸,Bridge Julia A.⁴,Krailo Mark D.³,Randall R. Lor¹²,Lessnick Stephen L.¹²⁹,

Affiliation:

1. Department of Orthopedics; University of Utah; Salt Lake City Utah

2. Center for Children's Cancer Research; Huntsman Cancer Institute; University of Utah; Salt Lake City Utah

3. University of Southern California Keck School of Medicine; Los Angeles California

4. Department of Pathology and Microbiology; University of Nebraska Medical Center; Nebraska Medical Center; Omaha Nebraska

5. Children's Oncology Group Biopathology Center; The Research Institute at Nationwide Children's Hospital; Columbus Ohio

6. Department of Pediatrics; Montefiore Medical Center; The Children's Hospital at Montefiore; Bronx New York

7. Division of Pediatric Hematology/Oncology; Department of Pediatrics; Stanford University; Palo Alto California

8. Division of Oncology; The Children's Hospital of Philadelphia; University of Pennsylvania; Philadelphia Pennsylvania

9. Division of Pediatric Hematology/Oncology and the Department of Oncological Sciences; University of Utah; Salt Lake City Utah

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference49 articles.

1. Ewing's sarcoma: A study of fifty cases treated at the Massachusetts General Hospital, 1930-1952 inclusive;Wang;N Engl J Med,1953

2. Ewing's sarcoma. A critical analysis of 165 cases;Dahlin;J Bone Joint Surg Ame,1961

3. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group;Womer;J Clin Oncol,2012

4. A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT 0006 1893;Felgenhauer;Pediatr Blood Cancer,2013

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma;Clinical Cancer Research;2024-03-20

2. Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031;Journal of Clinical Oncology;2023-10-20

3. Radiotherapy in bone sarcoma: the quest for better treatment option;BMC Cancer;2023-08-11

4. Molecular and biologic biomarkers of Ewing sarcoma: A systematic review;Journal of Bone Oncology;2023-06

5. Ewing sarcoma genomics and recent therapeutic advancements;Pediatric Hematology Oncology Journal;2023-03